Drug-eluting bone grafts areadvancements that can be utilized to treat issues like orthopedic surgery infection.
FREMONT, CA: The orthopedic devices market will remain a promising sector of the worldwide medical technology industry, with revenues predicted to rank third after cardiology and in-vitro diagnostics by 2020. According to a study, the sector produced 39.40 billion dollars in revenue in 2016, and revenue is predicted to expand at a CAGR of 3.3 percent to 44.82 billion dollars in 2020. The rise in orthopedic problems and the advent of advanced technologies will drive industry expansion.
Orthobiologics makes use of the human body's cells' regeneration ability. Orthobiologics are manufactured from natural chemicals found in the body and are used to help broken bones, injured muscles, ligaments, and tendons heal faster. Bone grafts, growth factors, stem cells, platelet-rich plasma, autologous blood, and autologous conditioned serum are available treatments. Bone marrow-derived mesenchymal stem cells (MSCs) have been shown to be useful in the creation of desired tissues.
Recent advancements in this sector, such as growth factors and stem cell-based treatments, are expected to speed up recovery times.Drug-eluting bone grafts are another advancement that can be utilized to treat issues like orthopedic surgery infection. Growth factors have been shown in clinical tests to hasten the healing process. Stem cells can renew and develop into any cell type indefinitely, making them an unrivaled supply of regenerative medicine technology. The following are some instances of stem cell-based musculoskeletal therapy.
Progenitor cells give rise to osteoblasts, which mature into mature bone cells, resulting in bone fractures and non-unions. This accelerates the repair of the broken bone by stimulating bone development.
Articular Cartilage: Articular cartilage is the lining of joints. The formation of primary hyaline cartilage is induced by stem cells, which repair the joint surface.
Ligaments and Tendons: MSCs mature into connective tissue-specific cells. This permits ligaments and tendons to repair more quickly.
Spine: Back discomfort is frequently caused by the deterioration of intervertebral discs. Injections of MSCs into degenerative discs have been found to decrease lower back pain and rebuild disc tissue.
Stem cells are being used in orthopedic treatments by biotechnology businesses. One firm, for example, specializes in stem cell therapies for age-related degenerative diseases, another specializes in adipose-derived stem cells for orthopedic problems, and a third specializes in orthobiological solutions for cartilage deformities.